Tag: veterinary vaccines market

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary Vaccines Market Poised To Hit $16.79 Billion By 2030 With A 6% CAGR

The veterinary vaccines market has experienced substantial expansion in recent years. It is projected to grow from $12.54 billion in 2025 to $13.28 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. This past growth can be attributed to factors such as the increasing prevalence of animal diseases, a rising livestock population, the growth in companion animals, government regulations that support vaccination, and advancements in vaccine research and production.

The veterinary vaccines market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $16.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This expansion during the projection period can be attributed to factors such as advancements in biopharmaceutical vaccine technologies, a growing need for preventive veterinary services, the increasing use of DNA and recombinant vaccines, the broadening of vaccination initiatives in developing economies, and heightened understanding of how to prevent zoonotic diseases. Key trends anticipated within this forecast timeframe encompass the creation of new livestock vaccines, an increase in vaccination programs for companion animals, the wider application of recombinant and toxoid vaccines, the uptake of combination vaccines targeting multiple diseases, and a strong emphasis on stopping the spread of zoonotic diseases.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=2456&type=smp&name=Veterinary%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Vaccines Market Growth Momentum: What Factors Are Shaping Demand?

A surge in the prevalence of various ailments affecting animals is projected to fuel the expansion of the veterinary vaccine market in the future. This condition, where non-human animals contend with simultaneous or consecutive burdens from multiple pathological states, leads to aggravated physical, psychological, and functional damage, significantly impacting their well-being. The escalation in animals afflicted by diverse diseases stems from inadequate sanitation and hygiene in their living environments. Veterinary vaccines assist animals facing various diseases by boosting their immune responses, thereby preventing infections, lessening disease severity, curbing transmission, and improving overall animal health and welfare. For example, in July 2025, the UK Health Security Agency, a UK-based government agency, reported 154 confirmed and probable cases of leptospirosis (a bacterial zoonotic infection) in 2024, representing an 11.6% rise from the 138 cases noted in 2023. Consequently, the growing number of animals afflicted by various diseases is a key factor propelling the expansion of the veterinary vaccine market.

Veterinary Vaccines Market Segment Performance And Emerging Opportunities

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

Veterinary Vaccines Market Trends Redefining Industry Growth

Leading companies in the veterinary vaccine market are developing novel products to gain a competitive advantage. These new offerings include sophisticated, disease-targeted veterinary vaccines featuring improved formulations, wider pathogen coverage, and enhanced safety and effectiveness profiles. For instance, in June 2023, US-based pharmaceutical company Merck Animal Health introduced Circumvent CML, a new three-in-one swine vaccine. This vaccine provides protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. It integrates multiple antigens and adjuvant systems into one bottle, thereby decreasing the necessary dosage volume. Administered as a single intramuscular dose to pigs aged three weeks or older, it streamlines the vaccination procedure and lessens stress for both the animals and their handlers.

Veterinary Vaccines Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

View The Full Veterinary Vaccines Market Report:

https://thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Vaccines Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Veterinary Vaccines Market From 2026 To 2030?

The veterinary vaccines market size has expanded significantly in recent years. This market is projected to expand from $12.54 billion in 2025 to $13.28 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.9%. Historically, this expansion has been driven by the increasing prevalence of animal diseases, a rising livestock population, the growth in companion animals, government regulations supporting vaccination, and advancements in vaccine research and production.

The veterinary vaccines market is expected to experience significant expansion in the coming years. It is projected to reach $16.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This growth throughout the forecast period can be attributed to several factors, including the emergence of new biopharmaceutical vaccine technologies, a rising demand for preventive veterinary care, the increasing adoption of DNA and recombinant vaccines, the broadening of vaccination programs in developing markets, and enhanced awareness regarding the prevention of zoonotic diseases. Notable trends anticipated during this period encompass the development of innovative livestock vaccines, the expansion of companion animal vaccination initiatives, the increased use of recombinant and toxoid vaccines, the integration of multi-disease combination vaccines, and a concentrated focus on preventing the transmission of zoonotic diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Major Growth Factors Are Impacting The Veterinary Vaccines Market?

The increase in the number of animals suffering from a range of diseases is expected to propel the growth of veterinary vaccine market going forward. Animals suffering from a range of diseases refers to non-human animals experiencing the concurrent or sequential burden of multiple pathological conditions, resulting in compounded physical, psychological, and functional harm that severely compromises their welfare. The increase in the number of animals suffering from a range of diseases is rising due to poor sanitation and hygiene conditions in animal habitats. Veterinary vaccines support animals suffering from a range of diseases by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and enhance overall animal health and welfare. For instance, July 2025, according to the UK Health Security Agency, a UK-based government agencies, in 2024, 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) were reported, an 11.6% increase from the 138 cases recorded in 2023. Therefore, the increase in the number of animals suffering from a range of diseases is driving the growth of the veterinary vaccine market.

Which Segment Divisions Form The Structure Of The Veterinary Vaccines Market?

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

What Trends Are Impacting The Veterinary Vaccines Market?

Major companies operating in the veterinary vaccine market are innovating new products to secure a competitive lead in the market. New products refer to advanced and disease-specific veterinary vaccines incorporating improved formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company launched a new three-in-one swine vaccine called Circumvent CML. This vaccine provides protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. The vaccine combines multiple antigens and adjuvant systems in a single bottle, reducing the required volume. It is administered as a single dose intramuscularly to pigs aged three weeks or older, simplifying the vaccination process and reducing stress for both animals and caretakers.

Who Are The Prominent Players Across The Veterinary Vaccines Market?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Region Leads The Veterinary Vaccines Market By Size?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

Get in touch with us:

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Bioengineered Protein Drugs Market Over The Period 2026–2030?

The veterinary vaccines market has demonstrated significant growth over recent years. This market is projected to expand from $12.54 billion in 2025 to $13.28 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.9%. The expansion observed in the past can be attributed to the increasing occurrence of animal diseases, a rising livestock population, the growing number of companion animals, government regulations that support vaccination, and advancements in vaccine research and production.

The veterinary vaccines market size is set for robust expansion over the next few years, with projections indicating growth to $16.79 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be credited to factors such as evolving biopharmaceutical vaccine technologies, an increasing need for preventive veterinary care, the implementation of DNA and recombinant vaccines, the scaling up of vaccination campaigns in emerging markets, and heightened awareness regarding the prevention of zoonotic diseases. Key trends expected in this forecast period include the development of new livestock vaccines, a rise in companion animal vaccination initiatives, the wider availability of recombinant and toxoid vaccines, the adoption of multi-disease combination vaccines, and a concerted effort to prevent the transmission of zoonotic diseases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Drivers Are Expected To Influence The Bioengineered Protein Drugs Market During The Forecast Period?

The rising prevalence of various ailments among animals is anticipated to boost the veterinary vaccine market. This phenomenon involves non-human animals experiencing simultaneous or consecutive multiple pathological conditions, leading to compounded physical, psychological, and functional harm that severely compromises their welfare. The increase in animals suffering from diverse diseases is attributed to poor sanitation and hygiene conditions in animal habitats. Veterinary vaccines assist these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and enhance overall animal health and welfare. For instance, in July 2025, the UK Health Security Agency, a UK-based government agency, reported 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) in 2024, marking an 11.6% increase from the 138 cases recorded in 2023. Consequently, the growing number of animals affected by a range of diseases is driving the expansion of the veterinary vaccine market.

How Is The Bioengineered Protein Drugs Market Divided Into Its Major Segments?

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

How Are Trends Transforming The Veterinary Vaccines Market Landscape?

Key players within the veterinary vaccine market are introducing novel products to establish a competitive edge. These new products encompass advanced and condition-specific veterinary vaccines that feature improved compositions, expanded pathogen coverage, and superior safety and efficacy attributes. For example, in June 2023, Merck Animal Health, a pharmaceutical company based in the US, unveiled Circumvent CML, a new three-in-one swine vaccine. This vaccine offers protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. It combines multiple antigens and adjuvant systems in a single bottle, which decreases the volume needed. Administered as a single intramuscular dose to pigs three weeks of age or older, it simplifies the vaccination process and reduces stress for both the animals and those caring for them.

Who Are The Prominent Organizations Shaping The Bioengineered Protein Drugs Market?

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Read the full veterinary vaccines market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Region Is Forecast To Lead The Bioengineered Protein Drugs Market In Terms Of Market Size?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioengineered Protein Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2026, By The Business Research Company

Companion Animal Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Bioengineered Protein Drugs Market Over The Period 2026–2030?

The veterinary vaccines market has demonstrated significant growth over recent years. This market is projected to expand from $12.54 billion in 2025 to $13.28 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.9%. The expansion observed in the past can be attributed to the increasing occurrence of animal diseases, a rising livestock population, the growing number of companion animals, government regulations that support vaccination, and advancements in vaccine research and production.

The veterinary vaccines market size is set for robust expansion over the next few years, with projections indicating growth to $16.79 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be credited to factors such as evolving biopharmaceutical vaccine technologies, an increasing need for preventive veterinary care, the implementation of DNA and recombinant vaccines, the scaling up of vaccination campaigns in emerging markets, and heightened awareness regarding the prevention of zoonotic diseases. Key trends expected in this forecast period include the development of new livestock vaccines, a rise in companion animal vaccination initiatives, the wider availability of recombinant and toxoid vaccines, the adoption of multi-disease combination vaccines, and a concerted effort to prevent the transmission of zoonotic diseases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Drivers Are Expected To Influence The Bioengineered Protein Drugs Market During The Forecast Period?

The rising prevalence of various ailments among animals is anticipated to boost the veterinary vaccine market. This phenomenon involves non-human animals experiencing simultaneous or consecutive multiple pathological conditions, leading to compounded physical, psychological, and functional harm that severely compromises their welfare. The increase in animals suffering from diverse diseases is attributed to poor sanitation and hygiene conditions in animal habitats. Veterinary vaccines assist these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and enhance overall animal health and welfare. For instance, in July 2025, the UK Health Security Agency, a UK-based government agency, reported 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) in 2024, marking an 11.6% increase from the 138 cases recorded in 2023. Consequently, the growing number of animals affected by a range of diseases is driving the expansion of the veterinary vaccine market.

How Is The Bioengineered Protein Drugs Market Divided Into Its Major Segments?

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

How Are Trends Transforming The Veterinary Vaccines Market Landscape?

Key players within the veterinary vaccine market are introducing novel products to establish a competitive edge. These new products encompass advanced and condition-specific veterinary vaccines that feature improved compositions, expanded pathogen coverage, and superior safety and efficacy attributes. For example, in June 2023, Merck Animal Health, a pharmaceutical company based in the US, unveiled Circumvent CML, a new three-in-one swine vaccine. This vaccine offers protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. It combines multiple antigens and adjuvant systems in a single bottle, which decreases the volume needed. Administered as a single intramuscular dose to pigs three weeks of age or older, it simplifies the vaccination process and reduces stress for both the animals and those caring for them.

Who Are The Prominent Organizations Shaping The Bioengineered Protein Drugs Market?

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Read the full veterinary vaccines market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Region Is Forecast To Lead The Bioengineered Protein Drugs Market In Terms Of Market Size?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioengineered Protein Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2026, By The Business Research Company

Companion Animal Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the longevity supplements market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Veterinary Vaccines Market in 2030?

The veterinary vaccines market size has seen strong growth in recent years. It is forecast to increase from $12.54 billion in 2025 to $13.28 billion in 2026, with a compound annual growth rate (CAGR) of 5.9%. This historical growth can be linked to the rising prevalence of animal diseases, an expanding livestock population, the increase in companion animals, government policies promoting vaccination, and progress in vaccine research and production.

The veterinary vaccines market is anticipated to experience robust expansion in the coming years. This market is projected to reach $16.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. Several factors are expected to drive this growth throughout the forecast period, including advancements in biopharmaceutical vaccine technologies, increasing demand for preventive veterinary care, the widespread adoption of DNA and recombinant vaccines, the expansion of vaccination initiatives in developing markets, and a heightened awareness regarding the prevention of zoonotic diseases. Key developments anticipated during this period encompass the creation of innovative livestock vaccines, the growth of companion animal vaccination programs, the proliferation of recombinant and toxoid vaccines, the uptake of multi-disease combination vaccines, and a dedicated focus on preventing the transmission of zoonotic diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Drivers Are Influencing Production Trends In The Veterinary Vaccines Market?

The escalating incidence of various diseases in animals is anticipated to propel the expansion of the veterinary vaccine market in the future. This encompasses non-human animals experiencing simultaneous or sequential burdens of multiple pathological conditions, leading to exacerbated physical, psychological, and functional harm that significantly compromises their well-being. The rise in the number of animals afflicted by a range of diseases is attributed to poor sanitation and hygiene conditions within animal habitats. Veterinary vaccines assist animals suffering from diverse diseases by stimulating their immune systems to avert infections, diminish disease severity, restrict transmission, and enhance overall animal health and welfare. For instance, in July 2025, the UK Health Security Agency, a UK-based government agency, reported 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) in 2024, representing an 11.6% increase from the 138 cases recorded in 2023. Therefore, the growing number of animals suffering from a range of diseases is driving the growth of the veterinary vaccine market.

Which Segment Groups Are Influencing The Veterinary Vaccines Market?

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

Which Trends Are Expected To Influence The Veterinary Vaccines Market In The Upcoming Years?

Major companies engaged in the veterinary vaccine market are introducing novel products to secure a competitive advantage. These new products encompass advanced and disease-specific veterinary vaccines, incorporating refined formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For example, in June 2023, Merck Animal Health, a US-based pharmaceutical entity, unveiled a new three-in-one swine vaccine named Circumvent CML. This vaccine provides protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. It combines several antigens and adjuvant systems in a single bottle, which reduces the necessary volume. Administered as a single intramuscular dose to pigs three weeks of age or older, it simplifies the vaccination process and minimizes stress for both the animals and their caretakers.

Who Are The Prominent Global Companies Shaping The Veterinary Vaccines Market Landscape?

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Veterinary Vaccines Market?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2026, By The Business Research Company

Companion Animal Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Veterinary Vaccines Market And What Value Is Projected For 2029?

The veterinary vaccines industry has seen considerable expansion lately, projected to escalate from a value of $11.89 billion in the year 2024 to reaching $12.54 billion in 2025, demonstrating a consistent compound annual growth rate (CAGR) of 5.4%; this upward trajectory during the preceding period stems from factors such as the expansion of developing regions, heightened expenditure on companion animals, a greater frequency of illnesses, the emergence of poultry disease outbreaks, and the increasing occurrence of diseases transmissible from animals to humans.

Anticipating robust expansion over the coming years, the veterinary vaccines market is projected to reach a valuation of $15.81 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.0%; this escalating expansion throughout the projection timeframe stems from factors such as broader economic development, heightened adoption of pet insurance, a surge in pet ownership numbers, greater governmental support and initiatives, alongside rising consciousness regarding animal well-being. Key developments shaping this market during the forecast involve substantial resource allocation toward the creation of nanoparticles, intensified manufacturing of vaccines based on subunits and virus-like particles, the consistent production stream of essential vaccines such as those for parvovirus, distemper, and adenovirus to satisfy routine inoculation requirements for pets, augmented capital expenditure in technological innovation, increased funding directed toward toxoid vaccines, a concentrated effort to boost investment in mRNA vaccine technology, and the forging of strategic alliances and cooperative agreements.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Factors Are Boosting The Veterinary Vaccines Market?

A growing incidence of various ailments affecting animals is fueling the need for preventative and therapeutic vaccines, thereby stimulating the veterinary vaccines market; for instance, the Animal and Plant Health Agency reported 3289 new instances of TB herds in England, and while concerns over bovine tuberculosis, a chronic condition impacting mammals like cattle and potentially resulting in severe illness, coughing, and fatality, persist, the availability of specialized antibiotics capable of eradicating the causative bacteria offers a means of intervention, meaning this escalating frequency of animal sickness is projected to propel market expansion over the forecast horizon.

What Are The Core Segmentation Criteria In The Veterinary Vaccines Market?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Which Emerging Trends Are Reshaping The Veterinary Vaccines Market Landscape?

Within the veterinary vaccines sector, there is a growing trend among firms toward establishing key alliances and joint efforts, primarily aimed at expanding into fresh territories and pooling resources for research and development initiatives. As an illustration, in February 2022, the American pharmaceutical enterprise Merck Animal Health entered into a four-year cooperative agreement with Iowa State University, a research institution situated in the US, with the goal of jointly developing novel animal health remedies. This cooperative arrangement will span various fields, including investigational work, production processes, investigating emerging technologies, commercial scaling, and other related areas, all working towards the common purpose of providing inventive answers to animal health difficulties both across the United States and globally. Furthermore, MSD Animal Health, which operates as a segment of Merck & Co and is headquartered in the US, established a strategic link with Vinovo; this collaboration is set to integrate MSD Animal Health’s diverse portfolio of vaccines with Vinovo’s vaccine administration platform, thereby enhancing avian well-being and minimizing adverse reactions to vaccination. Additionally, Wageningen bio veterinary research forged a strategic pact with the Switzerland-based Ceva to bolster their investigative work concerning the worldwide risks posed by animal diseases that are either newly appearing or resurfacing.

Which Players Are Shaping The Competitive Landscape Of The Veterinary VaccinesXX Market?

Major companies operating in the veterinary vaccines market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

What Regional Trends Are Shaping Growth In The Veterinary Vaccines Market?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2025, By The Business Research Company

Veterinary Medical Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report

Veterinary Anesthesia Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

Veterinary Patient Monitoring Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-patient-monitoring-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Veterinary Vaccines Market Expected To Become By 2029 Compared With Its 2025 Level?

The veterinary vaccines market size has seen significant expansion in recent years. It is forecast to increase from $11.89 billion in 2024 to $12.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.4%. This past growth can be attributed to factors such as the expansion of emerging markets, greater expenditure on pets, a rise in disease prevalence, more frequent outbreaks of poultry diseases, and the increasing incidence of zoonotic diseases.

The veterinary vaccines market is projected to experience substantial growth over the coming years. Its valuation is anticipated to reach $15.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.0%. This expansion during the forecast period is primarily driven by factors such as economic expansion, a greater adoption of pet insurance, an increase in pet ownership, expanded government programs, and a heightened consciousness regarding animal welfare. Key trends anticipated during this period encompass investments in nanoparticle development, a rise in the manufacturing of subunit and virus-like particle-based vaccines, the creation of vaccines targeting diseases like parvovirus, distemper, and adenovirus to support mandatory and routine pet owner vaccination schedules, increased funding for technological progress, greater investment in toxoid vaccines, an emphasis on boosting investment in mRNA vaccines, and forming strategic alliances and partnerships.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Are The Drivers Pushing New Developments In The Veterinary Vaccines Market?

The increasing incidence of various diseases affecting animals is elevating the requirement for vaccines to both prevent and treat these conditions, consequently stimulating the veterinary vaccines market. A report from the Animal and Plant Health Agency, for example, estimated that 3289 new TB herd incidents were identified in England. Bovine tuberculosis is a long-term illness that predominantly affects animals like cattle, but it can impact all mammals, causing general unwellness, coughing, and eventually leading to death. Although this disease can be managed with specific antibiotics that target the TB bacteria, the growing occurrence of animal diseases is projected to drive the veterinary vaccines market over the forecast period.

How Is The Veterinary Vaccines Market Segmented?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

What Key Innovation Trends Are Fueling Advancements In The Veterinary Vaccines Market?

Companies operating in the veterinary vaccines market are increasingly establishing strategic partnerships and collaborations to penetrate new geographical areas and to pool resources for research and development projects. An illustrative example occurred in February 2022, when Merck Animal Health, a US-based pharmaceutical company, formed a four-year strategic alliance with Iowa State University, a US-based research university, to collaboratively develop innovative solutions in animal health. This partnership’s extensive scope covers research and development, manufacturing, the investigation of new technologies, business expansion, and various other areas, all directed towards delivering creative solutions for animal health challenges across the US and worldwide. In a similar vein, MSD Animal Health, a US-headquartered division of Merck & Co, entered into a strategic partnership with Vinovo. This alliance aims to integrate MSD Animal Health’s broad vaccine product line with Vinovo’s vaccine delivery system into the vaccination process, consequently improving bird welfare and reducing vaccine reactions. Furthermore, Wageningen bio veterinary research initiated a strategic alliance with Ceva, based in Switzerland, with the goal of enhancing their research into the global threat of emerging and reemerging diseases for animals.

Which Leading Companies Dominate The Veterinary Vaccines Market Share?

Major companies operating in the veterinary vaccines market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Region Is Projected To Lead The Veterinary Vaccines Market During The Forecast Period?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Veterinary Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2025, By The Business Research Company

Veterinary Medical Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report

Veterinary Anesthesia Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

Veterinary Patient Monitoring Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-patient-monitoring-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Veterinary Vaccines Market Size from 2025 to 2034?

The market size for veterinary vaccines has experienced significant expansion in the past few years. An increase from $11.89 billion in 2024 to $12.54 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this historic growth include the expansion of emerging markets, a rise in spending on pets, enhanced prevalence of diseases, an uptick in the outbreak of poultry diseases, and a surge in the occurrence of zoonotic diseases.

The market for veterinary vaccines is predicted to witness significant expansion in the succeeding years. Its value is projected to escalate to $15.81 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.0%. Economic growth, the surge in pet insurance penetration, the rise in pet adoption, augmented government initiatives, and enhanced awareness about animal health are contributing factors to this growth during the projected period. The period is also expected to see key trends such as investments in nanoparticles development, an increase in the production of subunit and virus-like particle-based vaccines, manufacturing of vaccines like parvovirus, distemper, and adenovirus to adhere to the mandatory and regular vaccination schedule for pet owners. Technological advancement, increased investment in toxoid and mRNA vaccines, and strategic collaborations and partnerships will also witness considerable investment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Are the Core Market Drivers Propelling Growth in the Veterinary Vaccines Industry?

The escalating count of animals grappling with various illnesses is heightening the need for vaccines aimed at preventing and curing such conditions, thereby propelling the veterinary vaccines market. Based on estimations from a study conducted by the Animal and Plant Health Agency, there were 3289 new instances of TB herds found in England. Bovine tuberculosis, a chronic illness, typically impacts animals like cattle but can infect all mammals. It induces a general state of sickness, coughing and, ultimately, death. However, it can be effectively treated with specialized antibiotics aimed at exterminating the TB bacteria. The surging instances of animal diseases are anticipated to propel the veterinary vaccines market in the projected period.

How Is the Veterinary Vaccines Market Segmented?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Which Regions Are Driving the Next Phase of the Veterinary Vaccines Market Growth?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Veterinary Vaccines Industry?

To expand into new areas and collaborate on research and development projects, firms in the veterinary vaccines market are forming more strategic partnerships and alliances. For example, Merck Animal Health, a pharmaceutical company based in the United States, partnered with Iowa State University, a research university also in the U.S., for a strategic alliance lasting four years in February 2022. The agreement focuses on a range of areas including research and development, manufacturing, business growth, and the discovery of new technologies, all with the common aim of producing imaginative solutions for animal health issues in the United States and globally. MSD Animal Health, a division of Merck & Co based in the United States, also formed a strategic alliance with Vinovo. This partnership allows MSD Animal Health to integrate its unique wide-ranging vaccine product line with Vinovo’s vaccine delivery system for an enhanced vaccination process, ultimately improving bird welfare and reducing vaccine reactions. Similarly, Wageningen bio veterinary research collaborated strategically with Ceva, a company based in Switzerland, to enhance their research on the worldwide threat of emerging and re-emerging diseases in animals.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

How Is the Veterinary Vaccines Market Defined and What Are Its Core Parameters?

Veterinary vaccine refers to a biological preparation that stimulates the immune response of an animal against disease in order to reduce animal suffering and the transmission of microorganisms in the animal population and enhance the immunity power of animals by improving animal health, which also prevents the transmission of diseases from animals to humans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2456

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Veterinary Vaccines Market from 2024 to 2025?

The market size for veterinary vaccines has witnessed a robust growth in the past few years. The market is projected to surge from a value of $13.56 billion in 2024 to $14.52 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.1%. Factors such as the growth of emerging markets, heightened pet expenditures, a rise in disease prevalence, an upsurge in incidences of poultry diseases, and an increasing occurrence of zoonotic diseases have contributed to the growth during the historical period.

What Is the Projected Market Size of the Veterinary Vaccines Market?

Significant expansion is projected for the veterinary vaccines market over the upcoming years, with predictions indicating a surge to $19.4 billion by 2029, progressing at a CAGR of 7.5%. This anticipated growth during the forecast period can be credited to factors like economic development, higher pet insurance penetration, the upswing in pet ownership, escalated government initiatives, and a rising consciousness about animal health. During the forecast period, dominant trends comprise investing in nanoparticle development, escalating the production of subunit vaccines and virus-like particle-based vaccines, manufacturing of vaccines such as parvovirus, distemper, and adenovirus to meet the continuous vaccination requirements of pet owners, increased investment in technological advancements, amplified spending on toxoid vaccines, focus towards surging investment in mRNA vaccines, along with strategic alliances and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

Who are the Major Competitors in the Veterinary Vaccines Market Outlook?

Major companies operating in the veterinary vaccines market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

What Is Fueling Growth in the Veterinary Vaccines Market?

The growing number of animals affected by various diseases is heightening the need for vaccines as a preventative and treatment measure, thereby propelling the veterinary vaccines market. The Animal and Plant Health Agency’s report suggests that in England alone, there were 3289 new cases of TB identified among herds. Bovine TB, a chronic illness, predominantly impacts cattle and other mammals. It results in overall sickness, coughing, and can lead to death if left untreated. However, certain antibiotics are effective in eradicating the TB bacteria. The increasing incidence of such diseases in animals is projected to fuel the growth of the veterinary vaccines market in the coming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Which Veterinary Vaccines Market Segments Are Growing the Fastest?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Which Industry Trends Are Shaping the Future of the Veterinary Vaccines Market?

Firms in the veterinary vaccines sector are increasingly forming strategic alliances and collaborations to venture into new regions and share R&D projects. For instance, in February 2022, Merck Animal Health, a pharmaceutical firm based in the US, entered a four-year strategic partnership with the American research university, Iowa State University. This joint venture will involve collective efforts in R&D, manufacturing, technology exploration, business growth, and several other facets, all aimed at developing imaginative solutions to tackle animal health issues in the US and on a global scale. Similarly, another US-based department of Merck & Co, MSD Animal Health, strategically teamed up with Vinovo. This collaboration will empower MSD Animal Health to merge its unique wide vaccine product array with Vinovo’s vaccine delivery system, thereby boosting bird welfare and mitigating the impact of vaccine reactions. Additionally, Wageningen bio veterinary research joined strategic forces with the Switzerland-based Ceva to boost their study on the worldwide threat of arising and recurring diseases for animals.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Countries Are Leading the Veterinary Vaccines Market?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2456

This Report Delivers Insight On:

1. How big is the veterinary vaccines market, and how is it changing globally?

2. Who are the major companies in the veterinary vaccines market, and how are they performing?

3. What are the key opportunities and risks in the veterinary vaccines market right now?

4. Which products or customer segments are growing the most in the veterinary vaccines market?

5. What factors are helping or slowing down the growth of the veterinary vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the veterinary vaccines industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Veterinary Vaccines Market From 2025 To 2029?

The scale of the veterinary vaccines market has expanded notably in the past years. Its growth is projected to rise from $13.56 billion in 2024 to $14.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the historic phase include the expansion of emerging markets, growth in pet expenditures, rise in disease prevalence, escalation of poultry diseases, and an increase in the occurrence of zoonotic diseases.

In the coming years, the market size for veterinary vaccines is forecasted to see robust growth, reaching $19.4 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%. The expansion during the forecast period can be credited to economic development, heightened penetration of pet insurance, a surge in pet ownership, amplified government initiatives, and a rising consciousness about animal wellbeing. The forecast period will witness key trends including ventures into the development of nanoparticles, amplifying production of subunit and virus-like particle-based vaccines, production of vaccines such as parvovirus, distemper, and adenovirus in response to the mandated and routine vaccination schedules of pet owners. Moreover, the increase in investments in technological advancements, growing investment in toxoid vaccines, a renewed focus on amplifying investments in mRNA vaccines, and strategic collaborations and partnerships are expected.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary Vaccines Market?

Animal illnesses are on the rise, leading to an increased demand for vaccines to facilitate prevention and treatment. This scenario is what’s fuelling the growth of the veterinary vaccines market. A study by the Animal and Plant Health Agency identified 3289 new TB herd incidents in England alone. Bovine tuberculosis is a chronic ailment that typically affects animals like cattle – though it has the potential to affect all mammals. Symptoms range from a generic state of sickness to chronic coughing, ending in death. Yet, with specific antibiotics designed to eliminate the TB bacteria, treatment is possible. Due to this surge in animal-related diseases, the veterinary vaccines market is expected to grow throughout the forecast period.

Which Segments in the Veterinary Vaccines Offer the Most Growth?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary Vaccines Market?# Market?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Current Market Growth and Trends in the Veterinary Vaccines Industry?

Firms within the veterinary vaccines market are progressively establishing strategic alliances and collaborations to expand into fresh territories and share R&D efforts. For instance, Merck Animal Health, a pharmaceutical company based in the US, partnered strategically with Iowa State University, a research institution in the US, in a four-year strategic alliance in February 2022. This alliance aims to collaborate on inventive solutions in the field of animal health. The collaboration involves R&D, manufacturing, technology exploration, business growth, among other areas, all aiming to deliver innovative approaches to solve animal health issues within the US and globally. In a similar vein, MSD Animal Health, a unit of Merck & Co based in the US, entered into a strategic partnership with Vinovo. This alliance enables MSD Animal Health to integrate its unique wide range of vaccine product offerings with Vinovo’s vaccine delivery mechanism, thereby enhancing bird welfare and reducing vaccine reactions. Also, Wageningen bio veterinary research formed a strategic alliance with Switzerland-based Ceva, to bolster their research on the worldwide threat of new and recurrent diseases for animals.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

What Are the Key Elements That Define the Veterinary Vaccines Market?

Veterinary vaccine refers to a biological preparation that stimulates the immune response of an animal against disease in order to reduce animal suffering and the transmission of microorganisms in the animal population and enhance the immunity power of animals by improving animal health, which also prevents the transmission of diseases from animals to humans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2456

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model